Pharmaceuticals in Europe

Date: September 26, 2016
Pages: 37
Price:
US$ 350.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P0F573F8D4AEN
Leaflet:

Download PDF Leaflet

Pharmaceuticals in Europe
SUMMARY

Pharmaceuticals in Europe industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY FINDINGS
  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Europe
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Europe
  • Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the Europe pharmaceuticals market with five year forecasts
SYNOPSIS

Essential resource for top-line data and analysis covering the Europe pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

REASONS TO BUY
  • What was the size of the Europe pharmaceuticals market by value in 2015?
  • What will be the size of the Europe pharmaceuticals market in 2020?
  • What factors are affecting the strength of competition in the Europe pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in Europe's pharmaceuticals market?
KEY HIGHLIGHTS

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2015 annual average exchange rates.

The European pharmaceuticals market had total revenues of $205.2bn in 2015, representing a compound annual growth rate (CAGR) of 3.1% between 2011 and 2015.

The European market is mainly made up of very mature markets which are slow to produce growth and have domestic government policy aimed at reducing pharmaceutical expenditure.

The performance of the market is forecast to accelerate, with an anticipated CAGR of 4.2% for the five-year period 2015 - 2020, which is expected to drive the market to a value of $252.4bn by the end of 2020.
Executive Summary
Market value
Market value forecast
Geography segmentation
Market share
Market rivalry
Market Overview
Market definition
Market analysis
Market Data
Market value
Market Segmentation
Geography segmentation
Market share
Market Outlook
Market value forecast
Five Forces Analysis
Summary
Buyer power
Supplier power
New entrants
Threat of substitutes
Degree of rivalry
Leading Companies
Novartis AG
Pfizer Inc.
F. Hoffmann-La Roche Ltd
Sanofi SA
Methodology
Industry associations
Related MarketLine research
Appendix
About MarketLine

LIST OF TABLES

Table 1: Europe pharmaceuticals market value: $ billion, 2011-15
Table 2: Europe pharmaceuticals market geography segmentation: $ billion, 2015
Table 3: Europe pharmaceuticals market share: % share, by value, 2015
Table 4: Europe pharmaceuticals market value forecast: $ billion, 2015-20
Table 5: Novartis AG: key facts
Table 6: Novartis AG: key financials ($)
Table 7: Novartis AG: key financial ratios
Table 8: Pfizer Inc.: key facts
Table 9: Pfizer Inc.: key financials ($)
Table 10: Pfizer Inc.: key financial ratios
Table 11: F. Hoffmann-La Roche Ltd: key facts
Table 12: F. Hoffmann-La Roche Ltd: key financials ($)
Table 13: F. Hoffmann-La Roche Ltd: key financials (CHF)
Table 14: F. Hoffmann-La Roche Ltd: key financial ratios
Table 15: Sanofi SA: key facts
Table 16: Sanofi SA: key financials ($)
Table 17: Sanofi SA: key financials (€)
Table 18: Sanofi SA: key financial ratios

LIST OF FIGURES

Figure 1: Europe pharmaceuticals market value: $ billion, 2011-15
Figure 2: Europe pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 3: Europe pharmaceuticals market share: % share, by value, 2015
Figure 4: Europe pharmaceuticals market value forecast: $ billion, 2015-20
Figure 5: Forces driving competition in the pharmaceuticals market in Europe, 2015
Figure 6: Drivers of buyer power in the pharmaceuticals market in Europe, 2015
Figure 7: Drivers of supplier power in the pharmaceuticals market in Europe, 2015
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2015
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2015
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2015
Figure 11: Novartis AG: revenues and profitability
Figure 12: Novartis AG: assets and liabilities
Figure 13: Pfizer Inc.: revenues and profitability
Figure 14: Pfizer Inc.: assets and liabilities
Figure 15: F. Hoffmann-La Roche Ltd: revenues and profitability
Figure 16: F. Hoffmann-La Roche Ltd: assets and liabilities
Figure 17: Sanofi SA: revenues and profitability
Figure 18: Sanofi SA: assets and liabilities

COMPANIES MENTIONED

Novartis AG
Pfizer Inc.
F. Hoffmann-La Roche Ltd
Sanofi SA
Skip to top


OTC Pharmaceuticals in Europe US$ 350.00 Sep, 2016 · 39 pages
Pharmaceutical Distributors - Europe US$ 2,152.00 Aug, 2011
Pharmaceutical Manufacturers - Europe US$ 2,441.00 Aug, 2011

Ask Your Question

Pharmaceuticals in Europe
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: